Author Archives: admin

Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market

The transcript is found here May 19, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, CDC, Congress, FDA, Genetics, Infectious disease, NIH, Oncology | 9 Comments

Federal appeals court rules that our federal government violated the First Amendment during the pandemic

September 8, 2023- by Steven Greer (pro se litigator extraordinaire)

Posted in - Opinion, CDC, CMS, Congress, FDA, NIH | Leave a comment

Exclusive: The gender reassignment butchers have taken over my NYU surgery

September 5, 2023- by Steven E. Greer, MD Opinion-

Posted in - Opinion, CMS, Congress, Obstetrics and Gynecology, Pediatrics, Plastic surgery, Primary care medicine, Psychology Psychiatry | 1 Comment

Federal Court of Appeals Rules that FDA Overstepped by Restricting Ivermectin Use

September 2, 2023- by Steven E. Greer, MD

Posted in - Generics, - Pharma, CDC, Congress, FDA | Leave a comment

Ivermectin works as an antiviral against SARS-CoV-2 (COVID-19)

Update September 4, 2022- A new peer-reviewed study found that regular use of ivermectin reduced the risk of dying from COVID-19 by 92%.

Posted in - Biotech, - Generics, - Pharma, FDA, Infectious disease | Leave a comment

Ivermectin works against COVID in double blind, randomized, controlled trial

May 2, 2023- by Steven E. Greer, MD A new medical meeting poster shows the results of a double blind, randomized, controlled trial of ivermectin as a therapy for COVID. The drug works very well.

Posted in - Biotech, - Generics, - Pharma, Congress, Emergency medicine, FDA, Infectious disease, Internal Medicine | Leave a comment

Book: The Pfizer/Moderna mRNA Vaccine (i.e., gene therapy) Toxicity

September 1, 2023- by Sucharit Bhakdi, MD et al

Posted in - Biotech, - Pharma, - Reviews, books, devices, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology, Pediatrics | Leave a comment

Did the COVID vaccines change the human genome?

May 11, 2023- by Steven E. Greer, MD I was the first person on any large media platform to warn that the COVID vaccines would be hard to sell because they worked by altering our genes. I said this on … Continue reading

Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology | Leave a comment

Hospitals made out like bandits during the COVID pandemic

August 6, 2023- by Steven Greer, MD

Posted in Uncategorized | Leave a comment

Interview with Hélène Banoun about why mRNA “vaccines” should be regulated as gene therapies

July 12, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, Oncology | Leave a comment

Interview with drug trials expert Sasha Latypova on how the COVID vaccine approvals were a sham

July 7, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, - Policy, CDC, FDA, Infectious disease, NIH | Leave a comment

The Healthcare Channel hits 10

February 3, 2017- by Steven E. Greer, MD I don’t recall the exact date, but it was sometime during the summer of 2006, when I was daydreaming

Posted in - Opinion | Leave a comment

Rudy Giuliani interviews Steven E. Greer, MD on his podcast TV show: May 15, 2020

May 15, 2020

Posted in - Opinion, - Policy, Emergency medicine, Geriatrics, Infectious disease, Internal Medicine, Pulmonology | Leave a comment

Steven E. Greer MD: A discussion with Bill O’Reilly about radiation risks

April 1, 2011- A discussion with Bill O’Reilly about radiation risks from the Fukushima nuclear meltdowns and the fallout hitting the U.S. and entire globe.

Posted in - Policy, Congress, NYU, Ohio State, Oncology | Leave a comment

Rudy Giuliani interviews Steven E. Greer, MD on WABC radio- May 6, 2020

May 6, 2020

Posted in - Opinion, - Policy, CDC, CMS, Congress, Emergency medicine, FDA, Infectious disease, NIH | Leave a comment

Steven E. Greer, MD on OANN discussing virus therapies

April 16, 2020

Posted in - Biotech, - Generics, - Opinion, - Pharma, CDC, CMS, Congress, Emergency medicine, FDA, Geriatrics, Infectious disease, Internal Medicine, NIH, Pediatrics, Primary care medicine, Pulmonology, VA | Leave a comment

The Miami Summit on Healthcare Spending Reduction

June 29, 2010 Produced and interviewed by Steven Greer, MD The Healthcare Channel and The University of Miami Health System hosted a roundtable discussion

Posted in - Policy, CMS, Congress, Univ Miami | Leave a comment

Joe Piscopo interviews Steven E. Greer, MD: 5-22-2020

May 22, 2020

Posted in - Biotech, - Generics, - Opinion, - Pharma, - Policy, Emergency medicine, Infectious disease, Pulmonology | Leave a comment

FDA CDER Director on Benlysta for lupus and adaptive clinical trials.

July 27, 2011- Janet Woodcock, MD, Director of the FDAs new drug division, CDER, discusses with Steven Greer,

Posted in - Biotech, - Pharma, FDA, Rheumatology | Leave a comment

The Who’s Teen Cancer Lounge at Sloan Kettering opens

March 18, 2016- by Steven E. Greer MD The Memorial Sloan Kettering Cancer Center held a press day for its new teen lounge

Posted in Memorial Sloan-Kettering, Oncology | Leave a comment